Corgenix Medical Corporation (OTCBB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, today filed its fiscal quarter Form 10-Q and reported financial results. The report disclosed that the company achieved record operating results for the quarter ended September 30, 2013.
•Revenue for the quarter increased 2.0% to a record $2.88 million from $2.82 million in the same period of the prior year. Most of the growth was in AspirinWorks® product sales (up 72.5%) and contract manufacturing (up 46.2%).
Help employers find you! Check out all the jobs and post your resume.
